| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chondroitin sulfate binding | 5.58e-06 | 11 | 66 | 3 | GO:0035374 | |
| GeneOntologyMolecularFunction | glycosylceramide flippase activity | 3.22e-05 | 3 | 66 | 2 | GO:0140351 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 1.07e-04 | 28 | 66 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 1.19e-04 | 29 | 66 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 6.41e-04 | 51 | 66 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 6.41e-04 | 51 | 66 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | dystroglycan binding | 6.95e-04 | 12 | 66 | 2 | GO:0002162 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell development | 3.11e-05 | 3 | 67 | 2 | GO:0055014 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell differentiation | 3.11e-05 | 3 | 67 | 2 | GO:0055011 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 1.12e-05 | 14 | 67 | 3 | GO:1990531 | |
| Domain | - | 4.75e-06 | 32 | 66 | 4 | 3.40.1110.10 | |
| Domain | - | 4.75e-06 | 32 | 66 | 4 | 2.70.150.10 | |
| Domain | Hydrolase_3 | 4.97e-06 | 10 | 66 | 3 | PF08282 | |
| Domain | ATPase_P-typ_cyto_domN | 6.86e-06 | 35 | 66 | 4 | IPR023299 | |
| Domain | P_typ_ATPase | 7.69e-06 | 36 | 66 | 4 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 7.69e-06 | 36 | 66 | 4 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 7.69e-06 | 36 | 66 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 8.60e-06 | 37 | 66 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 8.60e-06 | 37 | 66 | 4 | PF00122 | |
| Domain | P_typ_ATPase_c | 1.49e-05 | 14 | 66 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 1.49e-05 | 14 | 66 | 3 | IPR032631 | |
| Domain | P-type_ATPase_IV | 1.49e-05 | 14 | 66 | 3 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 1.49e-05 | 14 | 66 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 1.49e-05 | 14 | 66 | 3 | PF16209 | |
| Domain | - | 7.70e-05 | 64 | 66 | 4 | 3.40.50.1000 | |
| Domain | HAD-like_dom | 1.75e-04 | 79 | 66 | 4 | IPR023214 | |
| Domain | Syntaxin/epimorphin_CS | 1.43e-03 | 16 | 66 | 2 | IPR006012 | |
| Domain | SYNTAXIN | 1.43e-03 | 16 | 66 | 2 | PS00914 | |
| Domain | CH | 1.57e-03 | 65 | 66 | 3 | SM00033 | |
| Domain | CH | 1.95e-03 | 70 | 66 | 3 | PF00307 | |
| Domain | - | 2.03e-03 | 71 | 66 | 3 | 1.10.418.10 | |
| Domain | CH | 2.20e-03 | 73 | 66 | 3 | PS50021 | |
| Domain | CH-domain | 2.37e-03 | 75 | 66 | 3 | IPR001715 | |
| Domain | SNARE | 2.47e-03 | 21 | 66 | 2 | PF05739 | |
| Domain | t_SNARE | 2.71e-03 | 22 | 66 | 2 | SM00397 | |
| Domain | T_SNARE | 3.78e-03 | 26 | 66 | 2 | PS50192 | |
| Domain | Homeobox_metazoa | 3.98e-03 | 90 | 66 | 3 | IPR020479 | |
| Domain | Homeobox_CS | 4.24e-03 | 186 | 66 | 4 | IPR017970 | |
| Domain | T_SNARE_dom | 4.70e-03 | 29 | 66 | 2 | IPR000727 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 3.86e-05 | 55 | 49 | 4 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 4.44e-05 | 57 | 49 | 4 | MM15643 | |
| Pubmed | 7.45e-08 | 5 | 69 | 3 | 12141427 | ||
| Pubmed | Phenotypic characterization of the murine Nkx2.6 homeobox gene by gene targeting. | 2.60e-07 | 7 | 69 | 3 | 10733590 | |
| Pubmed | 2.60e-07 | 7 | 69 | 3 | 10603087 | ||
| Pubmed | 6.22e-07 | 9 | 69 | 3 | 9344671 | ||
| Pubmed | Common arterial trunk associated with a homeodomain mutation of NKX2.6. | 3.88e-06 | 2 | 69 | 2 | 15649947 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 18939937 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 35055145 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 7904557 | ||
| Pubmed | Assignment of cardiac homeobox gene CSX to human chromosome 5q34. | 3.88e-06 | 2 | 69 | 2 | 7665173 | |
| Pubmed | Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis. | 3.88e-06 | 2 | 69 | 2 | 26314374 | |
| Pubmed | Lipocalin 2: a new mechanoresponding gene regulating bone homeostasis. | 3.88e-06 | 2 | 69 | 2 | 25112732 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 22653783 | ||
| Pubmed | The extracellular matrix protein agrin promotes heart regeneration in mice. | 1.16e-05 | 3 | 69 | 2 | 28581497 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 11180810 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 26334248 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 12040032 | ||
| Pubmed | NKX2-5, a modifier of skeletal muscle pathology due to RNA toxicity. | 3.86e-05 | 5 | 69 | 2 | 25168381 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 23168335 | ||
| Pubmed | Dystroglycan mediates homeostatic synaptic plasticity at GABAergic synapses. | 3.86e-05 | 5 | 69 | 2 | 24753587 | |
| Pubmed | 4.05e-05 | 1049 | 69 | 10 | 27880917 | ||
| Pubmed | 4.52e-05 | 653 | 69 | 8 | 22586326 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 9621431 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 25947375 | ||
| Pubmed | The murine homeobox genes Nkx2.3 and Nkx2.6 are located on chromosomes 19 and 14, respectively. | 8.09e-05 | 7 | 69 | 2 | 8001981 | |
| Pubmed | Six2 activity is required for the formation of the mammalian pyloric sphincter. | 8.09e-05 | 7 | 69 | 2 | 19660448 | |
| Pubmed | beta-Catenin is a Nek2 substrate involved in centrosome separation. | 1.08e-04 | 8 | 69 | 2 | 18086858 | |
| Pubmed | Identification of genes within the Krd deletion on mouse chromosome 19. | 1.08e-04 | 8 | 69 | 2 | 10087301 | |
| Pubmed | E2F6 initiates stable epigenetic silencing of germline genes during embryonic development. | 1.38e-04 | 9 | 69 | 2 | 34117224 | |
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 30106373 | ||
| Pubmed | 1.45e-04 | 251 | 69 | 5 | 31076518 | ||
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 22087235 | ||
| Pubmed | Nkx2.5 and Nkx2.6, homologs of Drosophila tinman, are required for development of the pharynx. | 1.73e-04 | 10 | 69 | 2 | 11390666 | |
| Pubmed | 2.03e-04 | 57 | 69 | 3 | 21122108 | ||
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 21914794 | ||
| Pubmed | A mouse chromosome 19 genetic map including the Lvis1 viral insertion site. | 2.53e-04 | 12 | 69 | 2 | 10051411 | |
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 2.98e-04 | 13 | 69 | 2 | 11015572 | |
| Pubmed | Identification of downstream genetic pathways of Tbx1 in the second heart field. | 2.98e-04 | 13 | 69 | 2 | 18328475 | |
| Pubmed | 3.48e-04 | 14 | 69 | 2 | 15613475 | ||
| Pubmed | Deletion of astroglial connexins weakens the blood-brain barrier. | 3.48e-04 | 14 | 69 | 2 | 22472609 | |
| Pubmed | 4.11e-04 | 486 | 69 | 6 | 20936779 | ||
| Pubmed | Unpackaging the genetics of mammalian fertility: strategies to identify the "reproductive genome". | 4.57e-04 | 16 | 69 | 2 | 29878059 | |
| Pubmed | Conditional expression of Wnt9b in Six2-positive cells disrupts stomach and kidney function. | 4.57e-04 | 16 | 69 | 2 | 22912798 | |
| Pubmed | Amerindian-specific regions under positive selection harbour new lipid variants in Latinos. | 4.57e-04 | 16 | 69 | 2 | 24886709 | |
| Pubmed | 4.57e-04 | 16 | 69 | 2 | 32469866 | ||
| Pubmed | 4.83e-04 | 326 | 69 | 5 | 17015433 | ||
| Pubmed | 4.97e-04 | 1429 | 69 | 10 | 35140242 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 5.16e-04 | 934 | 69 | 8 | 33916271 | |
| Pubmed | Molecular detection of maturation stages in the developing kidney. | 5.18e-04 | 17 | 69 | 2 | 33197428 | |
| Pubmed | Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis. | 5.18e-04 | 17 | 69 | 2 | 24737748 | |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 5.22e-04 | 186 | 69 | 4 | 33637726 | |
| Pubmed | 5.24e-04 | 332 | 69 | 5 | 25693804 | ||
| Pubmed | 5.33e-04 | 1442 | 69 | 10 | 35575683 | ||
| Pubmed | 5.76e-04 | 339 | 69 | 5 | 30415952 | ||
| Pubmed | 5.84e-04 | 340 | 69 | 5 | 29478914 | ||
| Pubmed | 6.49e-04 | 19 | 69 | 2 | 26490861 | ||
| Pubmed | Ovarian gene expression in the absence of FIGLA, an oocyte-specific transcription factor. | 6.49e-04 | 19 | 69 | 2 | 17567914 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 6.57e-04 | 349 | 69 | 5 | 25665578 | |
| Pubmed | 6.66e-04 | 971 | 69 | 8 | 33306668 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 6.67e-04 | 533 | 69 | 6 | 30554943 | |
| Pubmed | 7.63e-04 | 547 | 69 | 6 | 37267103 | ||
| Pubmed | 8.73e-04 | 22 | 69 | 2 | 29634390 | ||
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 9.76e-04 | 220 | 69 | 4 | 34091597 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.01e-03 | 1294 | 69 | 9 | 30804502 | |
| Pubmed | 1.14e-03 | 591 | 69 | 6 | 15231748 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.15e-03 | 1318 | 69 | 9 | 30463901 | |
| Pubmed | Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. | 1.18e-03 | 104 | 69 | 3 | 26167872 | |
| Pubmed | 1.23e-03 | 234 | 69 | 4 | 36243803 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.28e-03 | 605 | 69 | 6 | 28977666 | |
| Pubmed | NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. | 1.32e-03 | 27 | 69 | 2 | 23359859 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.35e-03 | 410 | 69 | 5 | 26949251 | |
| Pubmed | Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. | 1.42e-03 | 28 | 69 | 2 | 18587394 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 1.44e-03 | 847 | 69 | 7 | 35235311 | |
| Pubmed | 1.44e-03 | 847 | 69 | 7 | 35850772 | ||
| Pubmed | 1.62e-03 | 1116 | 69 | 8 | 31753913 | ||
| Pubmed | 1.74e-03 | 31 | 69 | 2 | 21072187 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.83e-03 | 440 | 69 | 5 | 34244565 | |
| Pubmed | Semaphorin 3E/PlexinD1 signaling is required for cardiac ventricular compaction. | 1.85e-03 | 32 | 69 | 2 | 31434798 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 1.93e-03 | 265 | 69 | 4 | 19240061 | |
| Pubmed | 1.97e-03 | 33 | 69 | 2 | 36522157 | ||
| GeneFamily | ATPase phospholipid transporting | 6.86e-06 | 15 | 46 | 3 | 1210 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 6.59e-04 | 67 | 46 | 3 | 519 | |
| GeneFamily | Syntaxins | 7.43e-04 | 16 | 46 | 2 | 818 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 4.42e-06 | 156 | 69 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Nefm_(dSPN)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.34e-06 | 80 | 69 | 4 | cb60461818f0900964d2a14c7f8462e7f37b3dff | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Nefm_(dSPN)|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.34e-06 | 80 | 69 | 4 | 27cc5ea77983fb0604545a0ff818eede8ba72b82 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 187 | 69 | 5 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 187 | 69 | 5 | 2591fe1552cd10925ad1d8d1f062a057ce6bdad9 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-05 | 88 | 69 | 4 | 1ca0e16981e88030987412e12838a9797b97b9c9 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 1.30e-05 | 195 | 69 | 5 | 5de6841fa04f6fe6f0c2aa6c300667a25ae6d52e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 196 | 69 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 196 | 69 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.44e-05 | 199 | 69 | 5 | f3cc3cda38f78d1d12d865df339d93c5fecf19f2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.44e-05 | 199 | 69 | 5 | c3c73c9404a73133bfad1f9ced292f5e508ef767 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-05 | 100 | 69 | 4 | cb0deaf1c33d2789417e93cc01d94e34a611d20a | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Rxfp1-Inhibitory_Gad1Gad2_Cplx3.Rxfp1_(Interneuron,_CA1_lacunosum_moleculare1?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.65e-05 | 53 | 69 | 3 | 2b60fc4908a523ce5f206e123ea181bee027ed9a | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Rxfp1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.65e-05 | 53 | 69 | 3 | 8b8698d8744055e9a2e6a9644a9d586945e55d6b | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Rxfp1-Inhibitory_Gad1Gad2_Cplx3.Rxfp1_(Interneuron,_CA1_lacunosum_moleculare1?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.65e-05 | 53 | 69 | 3 | 0160eee4269d3418a195d3caf312c0b57ab43f88 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.81e-05 | 146 | 69 | 4 | 159dd157a74f3c27dc1a1dcbbf0ed8f9462cac9e | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 8.90e-05 | 151 | 69 | 4 | 5906562efd36fbcb91f96e0a0d3a8fe999ba1e79 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.36e-05 | 153 | 69 | 4 | 5501095bcf73080872ae01128f21399f9cfc5dd1 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 158 | 69 | 4 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 158 | 69 | 4 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 162 | 69 | 4 | e17632778a57c71d6005d3abca3a0443a92040e7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 162 | 69 | 4 | ac4a80fd72c9311ea2b3e574c6284bbce4f2756c | |
| ToppCell | IIF-Other-HSPC|IIF / Disease, Lineage and Cell Type | 1.19e-04 | 163 | 69 | 4 | 1e0d38fbed38ac48478868a1480172a1a3f7c1b7 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.28e-04 | 166 | 69 | 4 | 59d47c1fca7a8c70f6998f3367a9dbcb9b67966f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.28e-04 | 166 | 69 | 4 | b4241f8d2a0aa910dbb0d0d5d3631a9b73453fe9 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 169 | 69 | 4 | 89b5452e0d8d058648a1d2659f1611fd6aebc6b6 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-04 | 172 | 69 | 4 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-ILC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.54e-04 | 174 | 69 | 4 | 7c50bf9da37711266cc077eef4e54b58463f1d37 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.71e-04 | 179 | 69 | 4 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | C_00|World / shred on cell type and cluster | 1.71e-04 | 179 | 69 | 4 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 1.71e-04 | 179 | 69 | 4 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-04 | 179 | 69 | 4 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-04 | 180 | 69 | 4 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-04 | 180 | 69 | 4 | 38490017dd590e3fcfa7e88d8d15235d55f90cf1 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-04 | 181 | 69 | 4 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-04 | 182 | 69 | 4 | 08aff7112c9dac0ef5540300516a604782b21169 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.86e-04 | 183 | 69 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-04 | 183 | 69 | 4 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 183 | 69 | 4 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.86e-04 | 183 | 69 | 4 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 183 | 69 | 4 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-04 | 184 | 69 | 4 | d48807f9da48bdd015a54c606d2e2a311f181396 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-04 | 187 | 69 | 4 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.06e-04 | 188 | 69 | 4 | 0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-04 | 188 | 69 | 4 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-04 | 189 | 69 | 4 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.11e-04 | 189 | 69 | 4 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 189 | 69 | 4 | 8a38baee58a27c2fa3f4bd131ab9f15723ed9295 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-04 | 190 | 69 | 4 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.24e-04 | 192 | 69 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.24e-04 | 192 | 69 | 4 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.24e-04 | 192 | 69 | 4 | 9a2560921b8c0997e1788053004f099439e8f071 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-04 | 192 | 69 | 4 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B1|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-04 | 76 | 69 | 3 | a3730df3d80a9285b26907d82db28a86039f62b6 | |
| ToppCell | tumor_Lung-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.28e-04 | 193 | 69 | 4 | 3655b7d5ee055c0067764a70e4a0b4724e7a4e85 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.28e-04 | 193 | 69 | 4 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 194 | 69 | 4 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 194 | 69 | 4 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 194 | 69 | 4 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD4+_Th|normal_Lymph_Node / Location, Cell class and cell subclass | 2.33e-04 | 194 | 69 | 4 | 208b56b2a1f5494b74f9423f2bdc2eb6d6023fa9 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 2.37e-04 | 195 | 69 | 4 | c60982804a74dbe6607c021799ca74af2204aba8 | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.37e-04 | 195 | 69 | 4 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 196 | 69 | 4 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 196 | 69 | 4 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 196 | 69 | 4 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 196 | 69 | 4 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.47e-04 | 197 | 69 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | mLN-T_cell-Th17|mLN / Region, Cell class and subclass | 2.52e-04 | 198 | 69 | 4 | 04905f62941b193864704a10ad692faf777fa51d | |
| ToppCell | mLN-(1)_T_cell-(13)_Th17|mLN / shred on region, Cell_type, and subtype | 2.52e-04 | 198 | 69 | 4 | c575e9aeee4e034e8c4d171fe754403652343731 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 198 | 69 | 4 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | mLN-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 2.52e-04 | 198 | 69 | 4 | 404ec46bd39b6f4d02a03ef38c30850bbbd8b608 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 198 | 69 | 4 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 199 | 69 | 4 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-04 | 199 | 69 | 4 | 9a08c25bb4851ad4ac9db8916422280f71378c2c | |
| ToppCell | mLN-(1)_T_cell-(11)_Activated_CD4_T|mLN / shred on region, Cell_type, and subtype | 2.56e-04 | 199 | 69 | 4 | 7da5a38f36ee10b95e07b2a8275cfb80c891d54c | |
| ToppCell | Sigmoid-T_cell-Th17|Sigmoid / Region, Cell class and subclass | 2.56e-04 | 199 | 69 | 4 | ff9bbfead7a8c7d1ba910ff1f9c6eb9a9774264c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-04 | 199 | 69 | 4 | 8d71e1fc92ee24deedf23fbb1a85a7fba0d8d436 | |
| ToppCell | Sigmoid-(1)_T_cell-(13)_Th17|Sigmoid / shred on region, Cell_type, and subtype | 2.56e-04 | 199 | 69 | 4 | 1b39191481faf2e8646a1405e30d8579031bd368 | |
| ToppCell | (1)_T_cell-(12)_Th1|(1)_T_cell / shred on Cell_type and subtype | 2.56e-04 | 199 | 69 | 4 | 15133e0a4ea6cfcc27c1d438d9e854879ea84c30 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-04 | 199 | 69 | 4 | 49690494270981eec5b5261c59e0545dff90cc21 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-04 | 199 | 69 | 4 | 2ed10c5e15c9d5ed0a8bea580842348d5698a07b | |
| ToppCell | mLN-T_cell-Activated_CD4_T|mLN / Region, Cell class and subclass | 2.56e-04 | 199 | 69 | 4 | 398eb1c809afb6ec711fb41563e11a3697730271 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 69 | 4 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-ILC|Multiple_Sclerosis / Disease, condition lineage and cell class | 2.61e-04 | 200 | 69 | 4 | ab9bdc9365cbdffe4ed246ce0c8a008a390e387e | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 69 | 4 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 69 | 4 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 69 | 4 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 69 | 4 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 69 | 4 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | (12)_Th1|World / shred on Cell_type and subtype | 2.71e-04 | 202 | 69 | 4 | 83a9267b1a40749fba5e812901d374278f15c969 | |
| ToppCell | (13)_Th17|World / shred on Cell_type and subtype | 2.77e-04 | 203 | 69 | 4 | e8d5db46093160d403ecd51142c3939d522bca8b | |
| ToppCell | (11)_Activated_CD4_T|World / shred on Cell_type and subtype | 2.82e-04 | 204 | 69 | 4 | 5c085c5335bf69c18fa298efa137e9bf529eefc6 | |
| Disease | progressive familial intrahepatic cholestasis (implicated_via_orthology) | 1.48e-05 | 3 | 66 | 2 | DOID:0070221 (implicated_via_orthology) | |
| Disease | CONOTRUNCAL HEART MALFORMATIONS | 2.95e-05 | 4 | 66 | 2 | 217095 | |
| Disease | Conotruncal heart malformations | 2.95e-05 | 4 | 66 | 2 | cv:C1857586 | |
| Disease | CONOTRUNCAL HEART MALFORMATIONS (disorder) | 7.35e-05 | 6 | 66 | 2 | C1857586 | |
| Disease | ventricular septal defect (is_implicated_in) | 4.41e-04 | 14 | 66 | 2 | DOID:1657 (is_implicated_in) | |
| Disease | 5-methyluridine (ribothymidine) measurement | 4.41e-04 | 14 | 66 | 2 | EFO_0020013 | |
| Disease | Tetralogy of Fallot | 5.79e-04 | 16 | 66 | 2 | C0039685 | |
| Disease | IgA glomerulonephritis (is_marker_for) | 9.12e-04 | 20 | 66 | 2 | DOID:2986 (is_marker_for) | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 1.11e-03 | 22 | 66 | 2 | C1843687 | |
| Disease | Anhedonia | 1.32e-03 | 24 | 66 | 2 | C0178417 | |
| Disease | cataract (is_implicated_in) | 1.55e-03 | 26 | 66 | 2 | DOID:83 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IKAVYDYWVRKRKNC | 171 | Q52LR7 | |
| LKVRCIKVQKIRYVW | 126 | Q4VNC1 | |
| HCLLNKKVREEYRKW | 786 | P48960 | |
| KKVREEYRKWACLVA | 791 | P48960 | |
| CKVRVWRYLKGKDLV | 66 | O00468 | |
| YFLKILKDLWCVRRK | 326 | P51684 | |
| LCWQRKKYKTNVIRT | 126 | O60423 | |
| RWQEVCKQLSDRKKR | 2191 | P11532 | |
| RYWKCRVRVIKSEDD | 406 | Q7Z478 | |
| RGYSWRKKNDCTKIK | 3216 | Q8IZT6 | |
| ERKEQTYVQKCWKDV | 156 | O94823 | |
| SRKEKKYIDRCWKDV | 161 | Q9P241 | |
| TEELKTWIKRVQKRY | 101 | Q15293 | |
| LKNWEIRERKKTREY | 461 | P49756 | |
| VKIWFQNRRYKCKRQ | 176 | A6NCS4 | |
| RQKREWVKFAKPCRE | 46 | P32926 | |
| AQEKWTLERLKRKYR | 81 | Q6NYC1 | |
| QVYRERQKYCKEWRK | 161 | Q9P2W1 | |
| LHVTERKYLKRDWCK | 81 | O60565 | |
| AYKVTKVKCWSVRER | 61 | Q14695 | |
| KREKAVGDKVYWTCR | 291 | Q4VC44 | |
| RASLKCYQWLKERIV | 316 | Q14722 | |
| KYLQRWREAVTARKK | 1241 | O60318 | |
| RKKTIKVWNCQDRDA | 166 | Q6X9E4 | |
| IKVLVWILVQYCSKR | 761 | Q63HM2 | |
| RWRVKCVQEVEEKKR | 276 | Q8N8D1 | |
| YCVKTRQIWEKILGK | 291 | Q8NH64 | |
| CRWILSVKKNYRKNV | 596 | O76074 | |
| LILCRKKVENTRWDY | 151 | Q9HB71 | |
| YVQCKVYVQLWKRLK | 216 | Q5T0T0 | |
| WKKRQVFKSLCREEA | 581 | Q8N9T8 | |
| QVKIWFQNRRYKCKR | 181 | P52952 | |
| TRLEEKSRIKCDQYW | 1491 | Q13332 | |
| VTSVLFRKKKCDYWI | 86 | P80188 | |
| YDECKRRFNIKLWKT | 136 | P62140 | |
| KKVLVWNRVYKVISR | 136 | Q569G3 | |
| ETCWKFFIEKVRRQL | 2911 | Q9UFH2 | |
| EKKYVSEKQLIHWRC | 26 | Q6XLA1 | |
| DYWRELEAKCKRQKA | 226 | Q6ZU35 | |
| VRKLQAKVLQYRSWC | 56 | Q9BV73 | |
| FCRRLLEWKQNVEKK | 606 | Q5T1N1 | |
| KNTCPRYIKWTQREK | 221 | Q15723 | |
| VWCKEVTKNYRGVKI | 451 | Q8NDI1 | |
| CRWYRNRKSKEPKKE | 141 | O14944 | |
| QRCKEVLEWRVKYSK | 46 | Q96MD7 | |
| QVKIWFQNRRYKCKR | 191 | Q8TAU0 | |
| KWRKRERSQQAELCK | 116 | O75364 | |
| WKCTVCFEDRNVKIK | 101 | Q4VX76 | |
| CCEQWRALEKERKKT | 761 | A2RUB1 | |
| YKNRVEGKVWCKIRK | 46 | Q5T2D2 | |
| KVWRKVVDRIFSLYK | 1731 | Q96Q15 | |
| KIWWNIRKTCYKIVE | 1176 | Q15858 | |
| ERCRQALRKELKTWK | 96 | Q8IY81 | |
| TLRKKWKDCKLRIYV | 931 | Q13621 | |
| LYSWQRERKVKTEFC | 96 | Q9NSE4 | |
| WLCTLSYKRVLQKTK | 126 | Q8TAV0 | |
| YQSKARRKKWIIIAV | 256 | P32856 | |
| EDQCWYRCKVLKIIS | 91 | Q9BXU1 | |
| VIKACSRKLYNWLRV | 741 | Q7KZ85 | |
| EQTLQRSWAYVKKCK | 266 | Q9Y6J8 | |
| YKARCWDEKELKNLR | 661 | Q8NDV3 | |
| QINIEKYQRCRIWDK | 36 | P56962 | |
| QKSWIERAFYKRECV | 61 | Q9HCF6 | |
| KIQKVCNKKLWERYT | 996 | Q9H2K2 | |
| CNKKLWERYTHRRKE | 1001 | Q9H2K2 | |
| EEYCEKVWCTDRKRK | 726 | O15041 | |
| NITKEKCKWYSERIH | 466 | Q502W6 | |
| VKRTWYKKFVGVQLC | 961 | Q7Z7G0 | |
| WQKYETARRLKKCVD | 441 | P11387 | |
| KKCVDKIRNQYREDW | 451 | P11387 | |
| FYQRVAKKDCIKKWI | 76 | Q86Y07 | |
| YRNRIKEKFCITWDK | 126 | Q86W24 |